THG Ventures
VC Fund
Beijing, China
THG Ventures is a VC fund in Beijing focused on Information Technology and Software. THG Ventures Co., Ltd. (hereinafter referred to as “THG Ventures”) is a venture capital management organization co-funded by Tsinghua Holdings Corporation Limited (hereinafter referred to as “Tsinghua Holdings”) and the fund management team, and controlled by the latter. The team of THG Ventures started in scientific and technologicalinvestment in 1999 as the first team that focused on RMB investment in China. This team successively established the “TusPark Incubator” and “TusPark Ventures” and set up a highly stable and experienced team of partners which raised and managed more than 10 venture capital funds in a professional and market-oriented way and invested in about 100 medium, small and micro-sized enterprises. They created a group of star pioneering enterprises, developed an investment concept and team culture with obvious Tsinghua characteristics, realized excellent and stable fund income and gained the recognition and continuous support of various types of contributors like government-guided funds, private capital, financial institutions and donation funds while making a continuous contribution to the development of the Tsinghua industry system. In 2016, THG Ventures became the management organization of a sub-fund of the National SME Development Fund, and raised a total of RMB 4.5 billion for the SME Development Fund (Jiangsu Nantong Limited Partnership). The team and core members of THG Ventures have won many influential awards in the industry, and have become a representative in RMB venture capital and a leader in domestic university industry equity investment.
- Total investments:
- 66
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Industries THG Ventures invests in
Stages THG Ventures invests in
Countries THG Ventures invests in
Round sizes
Contacts
1 more contact available
Round size
- Angel
- $425k–$425k
- Series A
- $1.4M–$16M
- Series B
- $2.8M–$28M
Investment Focus
Industry
- Information Technology 12 (18%)
- Software 9 (14%)
- Manufacturing 8 (12%)
- Hardware 6 (9%)
- Internet 6 (9%)
Stage
- Series A 24 (36%)
- Series B 13 (20%)
- Angel 10 (15%)
- Seed 6 (9%)
- Series C 4 (6%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Dalong Lv
Founding Partner
|
Founding Partner | Total investments: 1 | Find email | |
Zhuo Luo
Founding Partner and Managing Partner
|
Founding Partner and Managing Partner | Total investments: 0 | Find email | |
Jun Xue
Founding Partner
|
Founding Partner | Total investments: 0 | Find email | |
Lin Lei
Founding Partner
|
Founding Partner | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Darwin Cell Biology
|
Darwin Cell Biology is a biotechnology research and development platform. They provide research and development. They focus on drug research and development in the repair field, investing in special research and development in the fields of neurology, orthopedics, skin, tumors, rare diseases, etc., and having a pipeline of innovative substanceresearch and development. | Series C / Dec 08, 2025 | |
Feiling Optoelectronics
|
Feiling Optoelectronics is a technology company specializing in the supply of optical materials and specialty optical fibers. The company focuses on advanced manufacturing and preparation technologies for high-performance quartz materials used in optical fibers. Feiling develops innovative plasma-based processes to produce specialty optical fibersthat meet stringent industry requirements. Their products serve various sectors including telecommunications, industrial lasers, military, nuclear power, biomedicine, and energy. The company aims to enhance the localization and upgrading of optical fiber equipment and related preparation technologies to support high-end application markets. Feiling Optoelectronics is based in Wuhan, China, and is committed to advancing optical fiber technology through innovation and quality manufacturing. | $7M / Seed / Sep 09, 2025 | |
|
Darwin Cell Biology
|
Darwin Cell Biology is a biotechnology research and development platform. They provide research and development. They focus on drug research and development in the repair field, investing in special research and development in the fields of neurology, orthopedics, skin, tumors, rare diseases, etc., and having a pipeline of innovative substanceresearch and development. | $27.9M / Series C / Jul 30, 2025 | |
MindFlowing
|
ZGG.COM offers patent, trademark and copyright services. | Series C / Mar 31, 2025 | |
Iongen Therepeutics
|
Iongen Therepeutics is an innovative drug research and development company focusing on pain treatment. | $15M / Seed / Jan 15, 2025 | |
Baigong Semiconductor
|
Baigong Semiconductor is a high-tech firm specializing in integrated circuits, semiconductor device technologies as well as product design. | $14M / Venture - Series Unknown / Feb 04, 2024 | |
Shitong Microelectronics
|
Shitong Microelectronics specializes in the design and development of machine vision-detecting sensors, particularly 3D sensors. It seeks to create 3D sensors with high precision, low power consumption, and competitive prices. | $1.4K / Seed / Nov 13, 2023 | |
|
Robotphoenix
|
An industrial robot manufacturer in China | Series D / Mar 14, 2022 | |
HiScene
|
HiScene focuses on researching and developing core technologies and products for augmented reality. The company is committed to be an artificial intelligence company which provides the most natural human-computer interaction and explores the deepest data value. | $41.8M / Series C / Sep 09, 2021 | |
XiaoZao Tech
|
XiaoZao Tech is a farming processor dedicated to the R&D, cultivation, and production of microalgae EPA. | $15.5M / Series B / May 13, 2021 | |
| See all 66 investments → | |||
Co-Investors
TusStar
6 deals together
Oriental Fortune Capital
4 deals together
Hefei Hi-Tech Venture Capital
3 deals together
Lotus Lake Ventures
3 deals together
Shunwei Capital
3 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does THG Ventures invest in?
THG Ventures invests primarily in Information Technology, Software and Manufacturing startups, most often at Series A and Series B stage. Most of the 66 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is THG Ventures's check size?
THG Ventures typically joins rounds of $425k–$425k at Angel, $1.4M–$16M at Series A and $2.8M–$28M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds THG Ventures participates in.
How do I contact THG Ventures?
Public channels for THG Ventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at THG Ventures?
The team at THG Ventures includes Dalong Lv (Founding Partner), Zhuo Luo (Founding Partner and Managing Partner) and Jun Xue (Founding Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
